Tetsuru Karasawa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Ribavirin is one of the major agents used in combination therapy with interferon for chronic hepatitis C, but is often associated with hemolytic anemia as a serious adverse event. Employing metabolome analysis, we demonstrated that the concentrations of intermediate metabolites produced by glycolysis and the pentose phosphate cycle in patients' erythrocytes(More)
  • 1